 |
|
|
| |
Identification and Characterization of AB-452, a Potent
Small Molecule HBV RNA Destabilizer In Vitro and In Vivo
|
| |
| |
Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
DimitarGotchev, Min Gao, Chris Moore, Andrew Kondratowicz, Cory Abbott, Lauren Bailey, YingzhiBi, Robbin Burns, Shuai Chen, Tim Chiu, Bruce D. Dorsey, Ellen Evangelista, Laurel Fu, David Fraser, Fang Guo, Troy O.Harasym, Richard Holland, Agnes Jarosz, Salam Kadhim, Ramesh Kakarla, Kaylyn Kwak, Amy C. H. Lee, Alice H. L. Li, Fei Liu, Sara Majeski, Kevin McClintock, Angela Miller, Dan Nguyen, Chris Pasetka, LuyingPei, Stephen P. Reid, Rene Rijnbrand, Alexander Shapiro, Sunny Tang, XiaoweiTeng, Lucy Wang, Mark Wood, Xin Ye, and Michael J. Sofia
Arbutus Biopharma Inc., Warminster, PA, USA and Burnaby, BC, Canada
|
| |
|
|
|
|
|
